PureLabs S.p.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
PureLabs S.p.A. - overview
Established
2021
Location
Milan, -, Italy
Primary Industry
Healthcare
About
Based in Milan, Italy, and founded by Nino Lo Iacono in 2021, PureLabs s. r. l. is a medical services company that provides diagnostic laboratory services for the diagnosis of diseases.
In January 2026, PureLabs Srl raised EUR 21 million in venture funding from RedFish LongTerm Capital, Kayak Ventures and Boutique Italia, including TIBAG BETEILIGUNGEN, Mesel Holding, BLU ACQUARIO PRIMA SPA, Mazal Capital, and G. B. Par, The company provides health diagnostic services that can be accessed remotely as well. The offerings are centered on advanced diagnostic services delivered through a network of centers, with patient journeys oriented to prevention, wellness, and longevity.
It also highlights digital services that improve access and experience alongside multi‑specialty/ambulatory diagnostic services. The company generates revenue from diagnostic test volumes delivered through owned/affiliated centers, multi‑specialty outpatient services, and potentially digital add‑on services supporting monitoring and patient pathways. The company will use the January 2026 funding to support further expansion and strengthening high value‑added diagnostics and the group’s digital/technology systems.
Current Investors
Quadrivio Group, Alef 6 S.p.a., MarCap Corporation
Primary Industry
Healthcare
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Diagnostic Equipment
Website
www.purelabs.it/
Verticals
HealthTech
Company Stage
Early Stage
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.